No. Author

JournalVol. Page

Year

1

Aizawa N, Gandaglia G, Hedlund P, Fujimura T, Fukuhara H, Montorsi F, Homma Y, Igawa Y URB937, a peripherally restricted inhibitor for fatty acid amide hydrolase, reduces
prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent
nerve fibres in rats

BJU Int

117 821-8

2016

2

Aizawa N, Sugiyama R, Ichihara K, Fujimura T, Fukuhara H, Homma Y, Igawa Y:

Functional roles of bladder alpha1-adrenoceptors in the activation of single- unit primary
bladder afferent activity in rats

BJU Int

117 993-1001

2016

3

Aizawa N, Fukuhara H, Fujimura T, Homma Y, Igawa Y

Direct influence of systemic desensitization by resiniferatoxin on the activities of Aδ- and Cfibers in the rat primary bladder mechanosensitive afferent nerves.

Int J Urol

23952-6

2016

4

Akiyama Y, Morikawa T, Maeda D, Shintani Y, Niimi A, Nomiya A, Nakayama A, Igawa Y,Fukayama M, Homma Y

Increased CXCR3 Expression of Infiltrating Plasma Cells in Hunner Type Interstitial Cystitis.

Sci Rep

628652

2016

5Azuma T, Matayoshi Y, Sato Y, Sato Y, Nagase Y, Oshi M.

The safety and effect of chemotherapy with short hydration for urothelial cancer on patients'
quality of life.

Jpn J Clin Oncol

46958-963

2016

6

Fujimura T, Menon M, Fukuhara H, Kume H, Suzuki M, Yamada Y, Niimi A, Nakagawa T,Igawa Y, Homma Y

Validation of an educational program balancing surgeon training and surgical quality control
during robot-assisted radical prostatectomy

Int J Urol

23160-6

2016

Fujimura T, Inoue S, Urano T, Takayama K, Yamada Y, Ikeda K, Obinata D, Ashikari D,Takahashi S, Homma Y.

Increased expression of tripartite motif (TRIM) 47 is a negative prognostic predictor in human Clin Genitourinary
prostate cancer.
Cancer14298-303

2016

8Ito H, Aizawa N, Sugiyama R, Watanabe S, Takahashi N, Tajimi M, Fukuhara H, Homma Y,
Kubota Y, Andersson K E, Igawa Y

Functional role of the transient receptor potential melastatin 8 (TRPM8) ion channel in theurinary bladder assessed by conscious cystometry and ex vivo measurements of single-unitmechanosensitive bladder afferent activities in the rat

BJU Int

117 484-94

2016

9Ito H, Kamei J, Aizawa N, Fujita Y, Suzuki M, Fukuhara H, Fujimura T, Kojima T, Homma Y, Preventive Effects of Long-Term Caloric Restriction on Aging Related In Vivo Bladder
Kubota Y, Ito M, Andersson KE, Igawa Y
Dysfunction and Molecular Biological Changes in the Bladder and Dorsal Root Ganglia inRats.

J Urol196 1575-83

2016

JournalVol. PageYear

Int J UrolEpub2016

Int J Clin Oncol

Epub2016

7No. Author
Kawai T, Tanaka Y; Cancer Registration Committee of the Japanese Urological Association.
1011Title

Title
Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: Alarge-scale study from the Cancer Registration Committee of the Japanese UrologicalAssociation.

Makino K, Nakagawa T, Kanatani A, Kawai T, Taguchi S, Otsuka M, Matsumoto A, Miyazaki Biphasic decline in renal function after radical cystectomy with urinary diversion.
H, Fujimura T, Fukuhara H, Kume H, Homma Y

12 Makise N, Morikawa T, Nakagawa T, Ichimura T, Kawai T, Matsushita H, Kakimi K, Kume H, MAGE-A expression, immune microenvironment, and prognosis in upper urinary tract
Homma Y, Fukayama Mcarcinoma.

Hum Pathol

50 62-9

2016

13 Naito A, Taguchi S, Nakagawa T, Matsumoto A, Nagase Y, Tabata M, Miyakawa J, Suzuki M, Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary World J Urol
Nishimatsu H, Enomoto Y, Takahashi S, Okaneya T, Yamada D, Tachikawa T, Minowada S, bladder.
Fujimura T, Fukuhara H, Kume H, Homma YEpub2016

Epub2016

35 965-9

2016

Epub2016

Nakagawa T, Taguchi S, Uemura Y, Kanatani A, Ikeda M, Matsumoto A, Yoshida K, Kawai T,Nagata M, Yamada D, Komemushi Y, Suzuki M, Enomoto Y, Nishimatsu H, Ishikawa A,Nagase Y, Kondo Y, Tanaka Y, Okaneya T, Hirano Y, Shinohara M, Miyazaki H, Fujimura T, Nomogram for predicting survival of post-cystectomy recurrent urothelial carcinoma of the14bladder.
Fukuhara H, Kume H, Igawa Y, Homma YNiimi A, Nomiya A, Yamada Y, Suzuki M, Fujimura T, Fukuhara H, Kume H, Igawa Y,Homma Y

Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: Long-term
outcomes and prognostic predictors

16 Niimi A, Suzuki M, Yamaguchi Y, Ishii M, Fujimura T, Nakagawa T, Fukuhara H, Kume H,Igawa Y, Akishita M, Homma Y

Sleep Apnea and Circadian Extracellular Fluid Change as Independent Factors for Nocturnal
Polyuria.

15Urol Oncol

Neurourol Urodyn
J Urol

17 Nozaki K, Kamijo Y, Nakatsuka M, Azuma T, Nakagawa T, Miyazaki H, Fujimura T, Fukuhara Computed tomography for the management of exit-site and tunnel infections in peritoneal
H, Kume H, Ishibashi Y, Homma Ydialysis patients.

Clin Nephrol

86 328-32

2016

18 Obara W, Eto M, Mimata H, Kohri K, Mitsuhata N, Miura I, Shuin T, Miki T, Koie T, Fujimoto A phase I/II study of cancer peptide vaccine
H, Minami K, Enomoto Y, Nasu T, Yoshida T, Fuse H, Hara I, Kawaguchi K, Arimura A,
S-288310 in patients with advanced urothelial carcinoma of the bladder.
Fujioka T.

Ann Oncol

Epub

2016

No. Author

JournalVol. PageYear

Eur J Cancer

5739-49

2016

Oncogene

356350-8

2016

21 Otsuka M, Taguchi S, Nakagawa T, Kawai T, Morikawa T, Miyazaki H, Fujimura T, Fukuhara Lower ureteral lesion is an independent predictor of intravesical recurrence after radical
H, Kume H, Homma Y
nephroureterectomy for upper tract urothelial carcinoma

Urol Oncol

3459.e9-13

2016

22 Rosier PF, Kirschner-Hermanns R, Svihra J, Homma Y, Wein AJ

Neurourol Urodyn3536-8

2016

1920

Obinata D, Takada S, Takayama K, Urano T, Ito A, Ashikari D, Fujiwara K, Yamada Y,
Murata T, Kumagai J, Fujimura T, Ikeda K, Horie-Inoue K, Homma Y, Inoue S.

Title
ABHD2, an androgen target gene, promotes prostate cancer cell proliferation and resistant tochemotherapy.

Obinata D, Takayama K, Urano T, Suzuki T, Takahashi S, Fujimura T, Homma Y, Fujiwara K, Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant
Fukuda N, Nagase H, Aburatani H, Tsutsumi S, Inoue S.
prostate cancer growth.

ICS teaching module: Analysis of voiding, pressure flow analysis (basic module)

23 Sonpavde G, Pond G R, Choueiri T K, Mullane S, Niegisch G, Albers P, Necchi A, Di Lorenzo Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage
G, Buonerba C, Rozzi A, Matsumoto K, Lee J L, Kitamura H, Kume H, Bellmunt J
Therapy for Advanced Urothelial Carcinoma.

Eur Urol69634-41

2016

24 Suzuki M, Iguchi Y, Igawa Y, Yoshida M, Sanada H, Miyazaki H, Homma Y

Ultrasound-assisted prompted voiding for management of urinary incontinence of nursing home Int J Urol
residents: Efficacy and feasibility.

23786-90

2016

25 Taguchi S, Akamatsu N, Nakagawa T, Gonoi W, Kanatani A, Miyazaki H, Fujimura T,Fukuhara H, Kume H, Homma Y

Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for
Metastatic Urothelial Carcinoma

14237-43

2016

255-602016

26Taguchi S, Kume H, Fukuhara H, Morikawa T, Kakutani S, Takeshima Y, Miyazaki H,Fujimura T, Nakagawa T, Ishikawa A, Igawa Y, Homma Y

Clin Genitourin
CancerSymptoms at diagnosis as independent prognostic factors in retroperitoneal liposarcoma
4

Mol Clin Oncol

27 Taguchi S, Nakagawa T, Uemura Y, Matsumoto A, Nagase Y, Kawai T, Tanaka Y, Yoshida K, Validation of major prognostic models for metastatic urothelial carcinoma using a multiYamamoto S, Enomoto Y, Nose Y, Sato T, Ishikawa A, Fujimura T, Fukuhara H, Kume H,
institutional cohort of the real world
Homma YWorld J Urol

34163-71

2016

28 Taguchi S, Shiraishi K, Fukuhara H, Nakagawa K, Morikawa T, Naito A, Kakutani S,Takeshima Y, Miyazaki H, Nakagawa T, Fujimura T,Kume H, Homma Y

Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: Radiat Oncol
is ultra-early salvage radiotherapy beneficial?

11102

2016

No. Author

Title

Vol. PageYear

Jpn J Clin Oncol

Epub

2016

Int J Clin Oncol

Epub2016

Int J Clin Oncol

Epub2016

96268-73

2016

16898

2016

Epub2016

2930

Taguchi S, Fukuhara H, Morikawa T, Matsumoto A, Miyazaki H, Nakagawa T, Fujimura T,
Kume H, Igawa Y, Homma Y

Cessation of long-term adjuvant androgen deprivation therapy after radical prostatectomy: Is itfeasible?

Taguchi S, Shiraishi K, Fukuhara H, Nakagawa K, Morikawa T, Naito A, Kakutani S,Takeshima Y, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Homma Y

Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment forbiochemical recurrence in pT2-3N0M0 prostate cancer.

31 Tsuda Y, Nakagawa T, Shinoda Y, Kanatani A, Kawai T, Taguchi S, Yamada Y, Sawada R,
Kume H, Homma Y, Tanaka S, Kawano H

Skeletal related events and prognosis in urothelial cancer patients with bone metastasis.

32 Yamada Y, Fujimura T, Fukuhara H, Miyagawa J, Miyazaki H, Nakagawa T, Kume H, Homma Measuring Contact Pressure of Lower Extremities in Patients Undergoing Robot-Assisted
Y
Radical Prostatectomy.

JournalUrol Int

33 Yamada Y, Nakagawa T, Sugihara T, Horiuchi T, Yoshizaki U, Fujimura T, Fukuhara H, Urano Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor. BMC Cancer
T, Takayama K, Inoue S, Kume H, Homma Y

34 Yamada Y, Takayama KI, Fujimura T, Ashikari D, Obinata D, Takahashi S, Ikeda K, Kakutani A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits
S, Urano T, Fukuhara H, Homma Y, Inoue S
apoptosis in testicular germ cell tumor.

Cancer Sci

35 Yokoyama O, Nishizawa O, Homma Y, Takeda M, Gotoh M, Kakizaki H, Akino H, Hayashi K, Nocturnal polyuria and hypertension in patients with lifestyle-related diseases and overactive
Yonemoto K; OASIS project groupbladder.

J UrolEpub2016

Epub2016

Translation and reliability and validity testing of a Japanese version of the Intermittent SelfCatheterization Questionnaire.

Neurourol Urodynam37 Zaitsu M, Nakamura F, Toyokawa S, Tonooka A, Takeuchi T, Homma Y, Kobayashi Y

Risk of Alcohol Consumption in Bladder Cancer: Case-Control Study from a Nationwide
Inpatient Database in Japan.

Tohoku J Exp Med

239 9-15

2016

No. AuthorTitle

JournalVol. PageYearEpub2016

36 Yoshida M, Igawa Y, Higashimura S, Suzuki M, Niimi A, Sanada H.

1Doggweiler R, Whitmore KE, Meijlink JM, Drake MJ, Frawley H, Nordling J, Hanno P, Fraser A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic
MO, Homma Y, Garrido G, Gomes MJ, Elneil S, van de Merwe JP, Lin AT, Tomoe H
pain working group of the international continence society.

Neurourol Urodyn

2Fukuhara H, Ino Y, Todo T

Oncolytic virus therapy: A new era of cancer treatment at dawn.

Cancer Sci107 1373-9

2016

3Homma Y, Ueda T, Tomoe H, Lin AT, Kuo HC, Lee MH, Oh SJ, Kim JC, Lee KS

Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015.

Int J Urol

23542-92016

4

Kamei J, Homma Y

What are the predictive factors of severe conditions in acute obstructive pyelonephritis?

Urogenit Tract Infect1112-6

2016

No. Author

Title

JournalVol. PageYear1

Horiuchi T, Shimizu K, Sasaki K, Kato A, Homma Y

Granulocyte-Colony Stimulating Factor Producing Infiltrating Urothelial Carcinoma of the Left Urol Case Rep
Renal Pelvis: A Case Report.

10 11-13

2016

2Tajima S, Suzuki T, Yamada Y, Morikawa T, Minagawa D, Homma Y, Fukayama M

Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting
sarcomatoid change: a case report of a bladder carcinoma

Med Mol Morphol

49 182-7

2016

3Yasui M, Morikawa T, Nakagawa T, Miyakawa J, Maeda D, Homma Y, Fukayama M.

Urinary bladder carcinoma with divergent differentiation featuring small cell carcinoma,
sarcomatoid carcinoma, and liposarcomatous component.

Pathol Res PractEpub2016

No. Author

1

Homma Y, Nakagawa T

2

Taguchi S, Nakagawa T

Title
Optimal Dose and Duration of bacillus Calmette-Guerin Therapy for Urothelial Carcinoma of
the Bladder

Re: Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma:
H. Fukushima, Y. Nakanishi, M. Kataoka, K. Tobisu and F. Koga. J Urol 2016; 195: 26-32.

JournalVol. PageYear

J Urol195 9-10

2016

J Urol195 1951-1952

2016